Reversal of heart failure remodeling in women

Journal of Women's Health and Gender-Based Medicine

Volumn 9, Issue 5, 2000, Pages 513-519

  Levine, T Barry ^a   Levine, Arlene B ^a   Kaminski, Patricia ^a   Stomel, Robert J ^a  

^a Botsford Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOSORBIDE MONONITRATE; LISINOPRIL; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL;

ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; ISOSORBIDE DINITRATE; LISINOPRIL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR REMODELING;

EID: 0033918871     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/15246090050073594     Document Type: Article

References (33)

1. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248.
2. Cohn JN. Structural basis for heart failure: Ventricular remodeling and its pharmacological inhibition. Circulation 1995;91:2504.
3. Sabbah HN, Kono T, Stein PD, Mancini J, Goldstein S. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992;263:H266.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Group. N Engl J Med 1987;316: 1429.
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293.
6. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303.
7. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB. The effect of carvedilol on morbidity and mortality inpatients with chronic heart failure. N Engl J Med 1996;334:1349.
8. CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial. Lancet 1999;353:9.
9. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001.
10. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;25:1154.
11. Eichhorn EJ, Bedetto JB, Malloy CR, et al. Effect of beta-adrenergic blockage on myocardial function and energetics in congestive heart failure: Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation 1990;82:473.
12. Levine TB, Levine AB, Keteyian SJ, Narins B, Lesch M. Reverse remodeling in heart failure with intensification of vasodilator therapy. Clin Cardiol 1997;20: 697.
13. Schocken DD, Arriata MI, Laever PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301.
14. Ho KKL, Anderson KM, Kannel WB, Groossman W, Levy D. Survival after the onset of congestive cardiac failure in the Framingham Heart Study. Circulation 1993;88:107.
15. Senni M, Tribouilloy CM, Rodehffer RJ, et al. Congestive heart failure in the community: Trends in incidence and survival in a 10-year period. Arch Intern Med 1999;159:29.
16. Williams JF. Evolving concepts in congestive heart failure, part 1. Mod Concepts Cardiovasc Dis 1990;59: 43.
17. McKee PA, Castelli WP, McNamara PM, Kannel MB. The natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971;285:1441.
18. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of antagonism converting enzyme inhibitors on mortality and morbidity in heart failure. JAMA 1995;273:1450.
19. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997;30:27.
20. Pitt B, Zannad F, Remme WJ, et al., for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709.
21. Johnstone D, Limacher M, Rousseau M, et al. Clinical characteristics of patients in the studies of left ventricular dysfunction. Am J Cardiol 1992;70:894.
22. De Maria R, Gavazzi A, Recalcati F, Baroldi G, DeVita C, Camerini F, for the Italian Multicenter Cardiomyopathy Study Group (SPIC). Comparison of the clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am J Cardiol 1993;72: 580.
23. Chin MH, Goldman L. Gender differences in 1-year survival and quality of life among patients with congestive heart failure. Med Care 1998;36:1033.
24. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and current practices in heart failure. J Am Coll Cardiol 1993;22(Suppl):14A.
25. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women's hearts. Circulation 1999;99:2334.
26. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN, for the V-HeFT VA Cooperative Studies Group. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 1998;87(Suppl VI):VI-17.
27. Wong M, Johnson G, Shabetai R, et al., for the V-HeFT VA Cooperative Studies Group. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: Veterans Affairs Cooperative Studies V-HeFT I and II. Circulation 1993;87(Suppl VI):VI-65.
28. Bristow MR, Gilbert EM, Abraham WT, et al; for the MOCHA Investigators. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996;94:2807.
29. Lechat P, Escolano S, Golmard JL, et al; on behalf of the CIBIS Investigators. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1997;96:2197.
30. Tofler GH, Stone PH, Muller JE, et al., and the MILIS Study Group. Effect of sex and race on prognosis after myocardial infarction: Adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987;9:473.
31. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325: 221.
32. Tobin JN, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med 1987;107:19.
33. Khan SS, Nessim S, Gray R, Czer L, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: Evidence for referral bias. Ann Intern Med 1990;112:561.